Healthcare
SITC Science in Context: PD-1/VEGF Bispecifics: Where does the field head next?
SITC’s webinar examines scientific, clinical, regulatory, and investor perspectives on PD-1/VEGF bispecifics, including survival endpoints, toxicity, the rationale for dual immune
